Elevated maternal soluble checkpoint molecules predict autoimmune congenital heart block
Introduction: Type I interferon signature is a known risk factor for the development of autoimmune congenital heart block (CHB) after exposure to maternal anti-Ro/La autoantibodies [ref:1]. However, only about 2% of children born to mothers with the respective antibodies are affected, [for full text, please go to the a.m. URL]
Institutions
- Universidad de Antioquia (CO)
- German Rheumatism Research Centre (DE)
- Klinikum Ernst von Bergmann (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-09-18
- DOI
- https://doi.org/10.3205/24dgrh026
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00